ATE363916T1 - Die expression von cyclin g1 in tumoren - Google Patents

Die expression von cyclin g1 in tumoren

Info

Publication number
ATE363916T1
ATE363916T1 AT96937833T AT96937833T ATE363916T1 AT E363916 T1 ATE363916 T1 AT E363916T1 AT 96937833 T AT96937833 T AT 96937833T AT 96937833 T AT96937833 T AT 96937833T AT E363916 T1 ATE363916 T1 AT E363916T1
Authority
AT
Austria
Prior art keywords
protein
cyclin
polynucleotide encoding
cells
host
Prior art date
Application number
AT96937833T
Other languages
English (en)
Inventor
Erlinda Gordon
Frederick Hall
W Anderson
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of ATE363916T1 publication Critical patent/ATE363916T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Steroid Compounds (AREA)
AT96937833T 1995-11-01 1996-10-31 Die expression von cyclin g1 in tumoren ATE363916T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55148695A 1995-11-01 1995-11-01

Publications (1)

Publication Number Publication Date
ATE363916T1 true ATE363916T1 (de) 2007-06-15

Family

ID=24201472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96937833T ATE363916T1 (de) 1995-11-01 1996-10-31 Die expression von cyclin g1 in tumoren

Country Status (9)

Country Link
EP (1) EP0858346B1 (de)
JP (2) JP4117367B2 (de)
AT (1) ATE363916T1 (de)
AU (1) AU724439B2 (de)
CA (1) CA2236482C (de)
DE (1) DE69637123T2 (de)
ES (1) ES2288756T3 (de)
NZ (1) NZ538525A (de)
WO (1) WO1997016209A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100375183B1 (ko) * 1999-09-21 2003-03-08 주식회사 삼양제넥스 사이클린 ｇ 또는 그것의 유전자를 이용한 자궁근종 진단방법 및 진단 키트
IL151527A0 (en) * 2000-03-02 2003-04-10 Univ Southern California Mutated cyclyn g1 protein
US6825033B2 (en) 2000-03-02 2004-11-30 University Of Southern California Mutated cyclin G1 protein
WO2001079505A2 (en) * 2000-04-17 2001-10-25 Children's Hospital Research Foundation INHIBITION OF BONE TUMOR FORMATION USING ANTISENSE cDNA THERAPY
US9868961B2 (en) 2006-03-30 2018-01-16 The Regents Of The University Of California Methods and compositions for localized secretion of anti-CTLA-4 antibodies
CN102135544A (zh) * 2011-02-23 2011-07-27 中国人民解放军第二军医大学 cyclin G1蛋白的应用
JP5892666B2 (ja) * 2014-03-14 2016-03-23 国立大学法人大阪大学 細胞死促進剤
CN113444158B (zh) * 2020-03-27 2022-11-18 中国科学院微生物研究所 B-型细胞周期蛋白Cbc1及其编码基因在新生隐球菌致病性中的重要作用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821234A (en) * 1992-09-10 1998-10-13 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of proliferation of vascular smooth muscle cell
WO1995013375A1 (en) * 1993-11-10 1995-05-18 The Johns Hopkins University Tumor suppressor waf1

Also Published As

Publication number Publication date
AU724439B2 (en) 2000-09-21
JP2007209344A (ja) 2007-08-23
EP0858346A1 (de) 1998-08-19
EP0858346A4 (de) 2004-09-08
JPH11514884A (ja) 1999-12-21
JP4117367B2 (ja) 2008-07-16
DE69637123T2 (de) 2008-02-14
AU7528496A (en) 1997-05-22
CA2236482C (en) 2007-04-24
DE69637123D1 (de) 2007-07-19
NZ538525A (en) 2007-07-27
CA2236482A1 (en) 1997-05-09
ES2288756T3 (es) 2008-01-16
EP0858346B1 (de) 2007-06-06
WO1997016209A1 (en) 1997-05-09

Similar Documents

Publication Publication Date Title
Révész et al. Cysteamine-induced increase of cellular glutathione-level: a new hypothesis of the radioprotective mechanism
Gonzaga et al. Identification of the cross-link between human O 6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA
ATE198513T1 (de) Ptpalpha-bestimmung in der tumordiagnose und - prognose
EA199800391A1 (ru) Ингибирование роста опухоли антисмысловыми олигонуклеотидами к il-8 и il-8 рецептору
LU90710I2 (fr) Galanthamine ou ses sels d'addition acides
DE69433552D1 (de) An den zelloberflächenrezeptor hek bindendes cytokin
BR0213786A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
DK0991421T3 (da) Påvisning og modulering af IAP'er og NAIP i forbindelse med diagnose og behandling af proliferativ sygdom
EA199700280A1 (ru) Ингибиторы протеинкиназы с
DK0858467T3 (da) Materialer og fremgangsmåder angående identifikationen og sekventeringen af BRCA2 cancerfölsomhedsgen og anvendelser deraf
ATE354372T1 (de) Verwendung von mif-antagonisten zur krebstherapie
DE69507470D1 (de) Diagnose von krebs, dessen zellen das am tyrosin phosphorylierte crkl-protein exprimieren
ATE368682T1 (de) Als 2f1 bezeichnetes rezeptorprotein
DE69637123D1 (de) Die expression von cyclin g1 in tumoren
EP2366712A3 (de) TS10Q23.3 Tumorunterdrückung
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
HUP0100668A2 (hu) Virulenciával kapcsolatos nukleinsavszekvenciák és alkalmazásuk
BR9808221A (pt) Método de tratamento de tumor.
EP0756488A4 (de) Tumor-suppressor-gen und verfahren zum nachweis von krebs
DE60016405D1 (de) Neurodegenerative-erkrankung verwandtes gen
EP1012338A4 (de) Ein tumorsuppressor namens ts10q23.3
SE9500030L (sv) Förfarande för bestämning av metastatisk potentialhos tumörceller
EA199900256A1 (ru) Нуклеотидная и белковая последовательность маммастатина и способы применения
ATE271125T1 (de) Neuartige tyrosinkinase
EP0157613A3 (de) Monoklonale Antikörper spezifisch für menschliche Basalzellen und bösartige schuppenartige Zellproteine, Hybridome, Bösartigkeitstestverfahren und diagnostische Reagenssätze

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties